SS Innovations International, Inc.
SSII Nasdaq
SEC CIK 1676163
Follow SS Innovations International
Weekly email: filings, results
Revenue, last quarter
$6.3M
−50.7% vs same quarter last year
Net income
−$5.7M
−54.6% vs same quarter last year
EPS, diluted
−$0.03
−50% vs same quarter last year
Operating cash flow
−$6.4M
+14.7% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $42.5M | −$12.1M |
| FY24 | $20.6M | −$19.2M |
| FY23 | $5.9M | −$20.9M |
| FY22 | $1.4M | −$3.2M |
| FY21 | - | −$1.5M |
| FY20 | - | −$1.1M |
| FY19 | - | −$3.4M |
| FY18 | - | −$960.3K |
| FY17 | - | −$1M |
| FY16 | - | −$485K |
| FY15 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 46% | −19.3% | −28.5% |
| FY24 | 40.9% | −91.9% | −92.7% |
| FY23 | 12.3% | −345.1% | −355.4% |
| FY22 | 4.2% | −206% | −223.8% |
| FY21 | - | - | - |
| FY20 | - | - | - |
| FY19 | - | - | - |
| FY18 | - | - | - |
| FY17 | - | - | - |
| FY16 | - | - | - |
| FY15 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$22.2M |
| FY24 | −$10.2M |
| FY23 | −$15.8M |
| FY22 | −$6.2M |
| FY21 | - |
| FY20 | - |
| FY19 | - |
| FY18 | - |
| FY17 | - |
| FY16 | - |
| FY15 | - |
- SS Innovations International
- Healthcare median
Show the numbers
| Year | SS Innovations International | Healthcare median |
|---|---|---|
| FY25 | −28.5% | −30.6% |
| FY24 | −92.7% | −47% |
| FY23 | −355.4% | −58% |
| FY22 | −223.8% | −80.4% |
| FY21 | - | −71.9% |
| FY20 | - | −62.2% |
| FY19 | - | −46.3% |
| FY18 | - | −49.6% |
| FY17 | - | −45.9% |
| FY16 | - | −36% |
| FY15 | - | −38.4% |